(HealthDay)—Among men with very-low-risk prostate cancer (PCa) who meet criteria for active surveillance but undergo radical prostatectomy, African-American race is associated with poorer outcomes, with higher rates of ...
Jun 18, 2013
0
0
According to the American Cancer Society, nearly 40,000 women in the United States will succumb to breast cancer this year. Most of these women will die not from the primary tumor but rather tumor recurrence – the reappearance ...
Jun 13, 2013
0
1
A new patient protocol for aggressive and recurrent lymphoma that combines intensive chemotherapy and radioimmunotherapy (RIT) may become the most powerful cancer-killing therapy available, with the hope that patients' lymphoma ...
Jun 11, 2013
0
0
While some cancer survivors feel distressed about diet and body weight, exercise helps them feel they are taking back control of their health, Cornell researchers report in the Journal of Nutrition Education and Behavior ...
Jun 7, 2013
0
0
Cancer survivors who live in rural areas aren't as healthy as their urban counterparts, according to new research from Wake Forest Baptist Medical Center.
Jun 5, 2013
0
0
Aggressive forms of bladder cancer involve the protein PODXL – a discovery that could hold the key to improved treatment, according to researchers at Lund University, Uppsala University and KTH in Sweden.
May 23, 2013
0
0
Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina suggests that the therapy may not be more effective than older, ...
May 20, 2013
0
0
(HealthDay)—Liver transplants to treat a common type of liver cancer are a viable option for people infected with HIV, according to new research.
May 17, 2013
0
0
A study has identified microRNA-155 as a new independent prognostic marker and treatment target in patients with acute myeloid leukemia that has normal-looking chromosomes under the microscope (that is, cytogenetically normal ...
May 13, 2013
0
0
Predicting outcomes for cancer patients based on tumor-immune system interactions is an emerging clinical approach, and new research from Wake Forest Baptist Medical Center is advancing the field when it comes to the most ...
May 9, 2013
0
0
